Dr. Wee Tin Katherine Kao, MD

Dr. Kao practices at Harris Health Ben Taub Hospital in Houston, Texas, part of Harris County, TX.

Dr. Kao's NPI, 1578859237, was assigned on June 21, 2011. Dr. Kao graduated from Renaissance School of Medicine at Stony Brook University in 2011. Dr. Kao holds Texas license S2608.

Dr. Kao's primary practice is Harris Health Ben Taub Hospital, at 1504 Taub Loop, Houston, TX 77030 in Harris County. The practice phone is (713) 873-2000.

Dr. Kao's primary practice is Harris Health Ben Taub Hospital in Houston, Texas, part of Harris County, TX. Dr. Kao is also affiliated with Memorial Hermann-Texas Medical Center. The medical group on file is UT Physicians. Dmand AI also links Dr. Kao to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kao practices, 3 sites in all. Vendor and product names are available with a free account.

Facial plastic surgery is Dr. Kao's primary specialty in the NPI Registry, under taxonomy code 207YS0123X. Dr. Kao is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Kao's licenses on file in 3 states: Texas, Florida and Missouri.

CMS data shows 26 Medicare services from Dr. Kao across 2 procedure codes in 2024, all of them office visits, for 54 Medicare patients. Medicare paid $2,006 for them. Every service was in an office.

CMS counts 54 Medicare patients who saw Dr. Kao in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 72% have high cholesterol. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kao's median patient age at 47, with 55% women.

In 2024, Dr. Kao wrote 100 Medicare Part D claims for 37 patients. 100% of them were for generic drugs. CMS names the drug for 68 of them, across 4 drugs with 11 or more claims each, at $1,038 in total drug cost. In 2023, CMS named 75 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Kao for performance year 2024, reported as part of a group. Dr. Kao accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Kao, published from 2010 to 2019. 2019 was the busiest year, with 2. The most frequent topics are Biofilms, Microscopy, Electron, Scanning and Postoperative Complications. Dr. Kao has published most often in Laryngoscope. Dr. Kao's most frequent co-authors are Richard A. Chole, MD, John Jeonhwan Chi, MD and Richard Davis, FACS, MD.

CMS Open Payments shows 33 general payments to Dr. Kao from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. Osteomed LLC paid the most, $812.

Dr. Kao graduated from Renaissance School of Medicine at Stony Brook University in 2011.

Dr. Kao is in network with 23 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.